MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
Journal of Clinical Oncology, 2019 PURPOSE To develop a risk score for patients with advanced systemic mastocytosis (AdvSM) that integrates clinical and mutation characteristics. PATIENTS AND METHODS The study included 383 patients with AdvSM from the German Registry on Disorders of ...
M. Jawhar +24 more
semanticscholar +1 more source
Systemic Mastocytosis with Smoldering Multiple Myeloma: Report of a Case
Case Reports in Oncological Medicine, 2016 Systemic mastocytosis (SM) is a disease characterized by a clonal infiltration of mast cells affecting various tissues of the body. It is grouped into six different subtypes according to the World Health Organization classification. It is called indolent
Sassine Ghanem +4 more
doaj +1 more source
Mastocytosis: One Word for Different Diseases
Oncology and Therapy, 2018 Mastocytosis is a neoplastic disease originating from tissue infiltration by transformed mast cells. The diagnosis requires a high grade of suspicion due to the large variety of presenting symptoms. The World Health Organization classification recognizes
Marianna Criscuolo +3 more
doaj +1 more source
Pink verrucous plaque in a man with systemic mastocytosis [PDF]
, 2019 Porokeratosis ptychotropica is a rare and commonly misdiagnosed subtype of porokeratosis involving the body folds. We present a 53-year-old man with systemic mastocytosis who presented with a pruritic, verrucous plaque in the gluteal fold that showed ...
Fung, Maxwell A +4 more
core
Allergy, Volume 80, Issue 12, Page 3427-3429, December 2025.
Alessandro Buonomo +6 more
wiley +1 more source
Indolent systemic mastocytosis limited to the bone: a case report and review of the literature
São Paulo Medical JournalCONTEXT Systemic mastocytosis is defined as a clonal disorder of mast cells and their precursor cells and is currently classified as a myeloproliferative neoplasm.
Pedro Pinto-Lopes +4 more
doaj +1 more source
Cutaneous mastocytosis: Two pediatric cases treated with topical pimecrolimus. [PDF]
, 2010 Cutaneous mastocytosis is characterized by increased numbers of skin mast cells that release mediators causing pruritus, urticaria, and flushing. Most pediatric mastocytosis patients exhibit the pattern of urticaria pigmentosa, which typically appears ...
Azevedo, R +4 more
core +1 more source
Systemic Mastocytosis as a Rare Cause of Pulseless Electrical Activity (PEA) Cardiac Arrest and Recurrent Syncope [PDF]
, 2016 M. Nangrahary, David Chieng, Arnon Keren
openalex +1 more source
Erhöhte basale Serumtryptasekonzentration oder Mastozytose als Risikofaktor der Hymenopterengiftallergie Leitlinie der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (DGAKI) (AWMF-Leitlinie 061/018) [PDF]
, 2017 Hymenopterengift-allergische Patienten mit Mastzellerkrankung, das heißt Mastozytose und/oder erhöhtem basalen Serumtryptasespiegel, haben ein hohes Risiko schwerer, lebensbedrohender Stichreaktionen.
Jarisch, Reinhart +3 more
core